Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accuracy, Acta, African, ainterferon, al, Allogeneic, Allouche, Amgen, Amit, Amlat, anemia, anemic, Antecip, antitumor, aranesp, arena, BA, Barzilay, Baz, BCNT, Bedford, begun, belief, bid, Binghamton, Biogal, BJH, bleeding, Boaz, BOLT, bore, bortezomib, Boulevard, boutique, breast, bring, broadly, broken, BS, burden, Canada, CERA, cervical, CFO, chairperson, chemotherapy, Cleveland, clonal, cloning, Cohen, colon, commerce, compartment, compromise, constipation, correlate, corroborate, corroborated, couple, creation, culmination, culture, cyclophosphamide, Dafna, Dauphine, David, deconsolidated, deconsolidation, Deleware, departure, deregister, devastating, dexamethasone, diagnosed, Diament, diplomatic, disruption, distressed, doxorubicin, Electrical, element, Eliezer, Emblaze, Engineering, ENST, EPO, Epogen, erythroid, erythropoietin, Eur, Eurocom, Euronext, exit, Exp, experimental, explanatory, forfeited, formal, Forty, Foundation, France, Francisco, French, frontline, ft, Gal, gene, geopolitical, Ghera, Gibraltar, Gilat, GLT, glycoprotein, Grossman, growth, Haematol, haematopoietic, Haran, Harel, HARL, Hasapir, Haverfield, Hb, hearing, heart, Hematol, hematological, Hematology, hemoglobin, Herman, Herzliya, HGII, hierarchy, hitherto, Hong, Horowitz, imminent, imminently, inclined, induced, INGA, insert, Interdisciplinary, intracellular, introduction, isal, Jaron, Johnson, Journal, Kanter, Katz, kidney, Kong, landlord, leaving, led, lenalidomide, Lifshitz, lineage, lookback, Ludwig, lymphoproliferative, malignancy, malignant, Marc, MBA, MDS, mediated, Mega, melphalan, men, Meretz, MGOR, Mittelman, MM, modulation, monetization, Mor, mortality, Moshe, myelodysplastic, myeloma, narrow, nausea, Nessuah, Neumann, Newer, newly, NYSE, observable, observation, Oncol, Orange, Oren, organelle, Oster, OTC, pathological, PCT, Peled, penny, pink, pivotal, plasma, PO, prednisone, prescription, problem, Procrit, progenitor, prognostic, proliferation, prolong, prolongation, propensity, proteasome, Qualification, Quoque, receptor, refractory, regression, relapse, relapsed, remedy, remission, residual, retail, revlinmid, rHuEPO, Roche, Rund, running, Russel, Sahar, SAIN, San, Satcom, Schweiger, Sean, secondary, sector, SGPA, shelf, shell, Shweiger, Skaat, slate, slower, sparingly, split, sq, stayed, stem, stimulating, stockholder, substantive, Suga, suppression, surprisingly, suspension, Swedish, SWOG, synergistic, Tagor, taint, Telecom, teratogenicity, TGCP, thalidomide, thrombophilia, today, Treasurer, tumor, tumorsAnn, tumour, unattractive, unclear, unobservable, unprecedented, Velcade, venture, viability, vincristine, vital, vol, vomiting, Wallvik, warn, warned, warning, Waterhouse, white, Wilmington, women, Yonay, Zanex, Zeidman
Removed:
abovementioned, Albany, annum, Arad, area, assignment, awarded, baseline, begin, Ben, Berlex, biology, Buffalo, Bulgarian, burn, CCI, Cinema, Clark, commitment, conditional, Copaxone, CPA, Cravath, Czech, Dentistry, depending, deterioration, Doctor, Doctorate, Dr, earned, Edinburgh, encounter, Encouragement, endpoint, Ernst, exclusivity, extend, fellowship, figure, formulation, founder, fourth, Fudim, fulfilling, funded, GlaxoSmithKline, goal, Haifa, Hapoalim, Heriot, hired, hiring, Ido, inclusion, Incubator, innovative, intragroup, joined, joining, Kalipharma, Kasirer, Kellner, Kennedy, KERX, Lahak, libor, managed, measurable, mg, Moore, moving, mutual, NY, obsolescence, occurring, Oncology, Paramount, parliament, Pfizer, physical, plc, post, Prize, profile, ranking, reach, renew, reorganization, repay, replacing, reproducing, Republic, retired, Rothschild, satisfactory, Searle, Seltenreich, SFKT, Shany, Shrem, Siena, stipulated, studied, SUNY, Swaine, Tashik, Teva, thirty, tolerability, tolerated, unaware, undistributed, Vered, Watt, Weiner, William, Yale, Young, Zeneca, Zion
Filing tables
Filing exhibits
XTLB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (File No. 333-141529, File No. 333-147024 and File No. 333-153055), the Registration Statements on Form S-8 (File No. 333-148085, File No. 333-148754 and File No. 333-154795) and related Prospectuses of XTL Biopharmaceuticals Ltd. of our report dated April 6, 2009 relating to the financial statements, financial statement schedules and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
/s/ Kesselman & Kesselman
Certified Public Accountant (Isr.)
A member of PricewaterhouseCoopers International Limited
Tel Aviv, Israel
April 6, 2009